RA
CELG

Riverside Advisors’s Celgene Corp CELG Stock Holding History

Riverside Advisors’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q2 		$795K Buy
+13,600
New +$818K 5.42% 6

Other funds holding CELG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Riverside Advisors's CELG Position: Q2 2013 in Review

Riverside Advisors opened a new position in Celgene Corp (CELG) in Q2 2013: 13,600 shares worth $795K. The stake represents 5.42% of the portfolio and ranks #6 among its holdings.

866 funds tracked by Wall St. Rank hold CELG as of Q2 2013.

  • Riverside Advisors held 13,600 shares of Celgene Corp worth $795K as of Q2 2013.
  • Celgene Corp was a new Riverside Advisors position in Q2 2013.
  • Celgene Corp made up 5.42% of Riverside Advisors's portfolio in Q2 2013, its #6 holding.
  • 866 funds tracked by Wall St. Rank held Celgene Corp as of Q2 2013.

Based on Riverside Advisors's 13F filing for Q2 2013, filed 9 Aug 2013.